Tofacitinib in chronic non-bacterial osteitis: a potential therapeutic option for multifocal osteitis

Vrushal Kale, Sandeep Yadav, Balakrishnan Canchi

Open source

DOI
10.4078/jrd.2025.0051
Published
2025-07-17
Container
Journal of Rheumatic Diseases
Publisher
Korean College of Rheumatology
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4078/jrd.2025.0051,
  title = {Tofacitinib in chronic non-bacterial osteitis: a potential therapeutic option for multifocal osteitis},
  author = {Vrushal Kale and Sandeep Yadav and Balakrishnan Canchi},
  year = {2025},
  journal = {Journal of Rheumatic Diseases},
  doi = {10.4078/jrd.2025.0051},
  url = {https://doi.org/10.4078/jrd.2025.0051}
}

RIS

TY  - JOUR
TI  - Tofacitinib in chronic non-bacterial osteitis: a potential therapeutic option for multifocal osteitis
AU  - Vrushal Kale
AU  - Sandeep Yadav
AU  - Balakrishnan Canchi
PY  - 2025
JO  - Journal of Rheumatic Diseases
DO  - 10.4078/jrd.2025.0051
UR  - https://doi.org/10.4078/jrd.2025.0051
ER  - 

APA

Kale, V., Yadav, S., & Canchi, B. (2025). Tofacitinib in chronic non-bacterial osteitis: a potential therapeutic option for multifocal osteitis. Journal of Rheumatic Diseases. https://doi.org/10.4078/jrd.2025.0051

Source records